Emcure Pharma IPO vs Stanley Lifestyles IPO

Comparision between Emcure Pharma IPO and Stanley Lifestyles IPO.

IPO Details

Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Stanley Lifestyles IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Emcure Pharma IPO	Stanley Lifestyles IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited	Axis Capital Limited ICICI Securities Limited Jm Financial Limited SBI Capital Markets Limited
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Emcure Pharma IPO is up to ₹1,952.03 Cr whereas the issue size of the Stanley Lifestyles IPO is up to ₹537.02 Cr. The final issue price of Emcure Pharma IPO is ₹1,008.00 per share and of Stanley Lifestyles IPO is ₹369.00 per share.

	Emcure Pharma IPO	Stanley Lifestyles IPO
Face Value	₹10 per share	₹2 per share
Issue Price (Lower)	₹960.00 per share	₹351.00 per share
Issue Price (Upper)	₹1,008.00 per share	₹369.00 per share
Issue Price (Final)	₹1,008.00 per share	₹369.00 per share
Discount (Retail)
Discount (Employee)	₹90.00 per share
Market Lot Size	14 shares	40 shares
Fresh Issue Size	79,36,507 shares	54,20,054 shares
Fresh Issue Size (Amount)	up to ₹800.00 Cr	up to ₹200.00 Cr
OFS Issue Size	1,14,28,839 shares	91,33,454 shares
OFS Issue Size (Amount)	up to ₹1,152.03 Cr	up to ₹337.02 Cr
Issue Size Total	1,93,65,346 shares	1,45,53,508 shares
Issue Size Total (Amount)	up to ₹1,952.03 Cr	up to ₹537.02 Cr

IPO Timetable

Emcure Pharma IPO opens on Jul 03, 2024, while Stanley Lifestyles IPO opens on Jun 21, 2024. The closing date of Emcure Pharma IPO and Stanley Lifestyles IPO is Jul 05, 2024, and Jun 25, 2024, respectively.

	Emcure Pharma IPO	Stanley Lifestyles IPO
Anchor Bid Date	Jul 02, 2024	Jun 20, 2024
Issue Open	Jul 03, 2024	Jun 21, 2024
Issue Close	Jul 05, 2024	Jun 25, 2024
Basis Of Allotment (Tentative)	Jul 08, 2024	Jun 26, 2024
Initiation of Refunds (Tentative)	Jul 09, 2024	Jun 27, 2024
Credit of Share (Tentative)	Jul 09, 2024	Jun 27, 2024
Listing date (Tentative)	Jul 10, 2024	Jun 28, 2024
Anchor Lockin End date 1	Aug 07, 2024	Jul 26, 2024
Anchor Lockin End date 2	Oct 06, 2024	Sep 24, 2024

Financials

Emcure Pharma IPO P/E ratio is 34.55, as compared to Stanley Lifestyles IPO P/E ratio of 54.43.

Emcure Pharma IPO

Stanley Lifestyles IPO

Financial

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,806.16	6,672.53	6,063.47
Revenue	6,715.24	6,031.72	5,918.86
Profit After Tax	527.58	561.85	702.56
Net Worth	2,952.28	2,501.13	1,987.55
Reserves and Surplus	2,722.40	2,293.77	1,791.03
Total Borrowing	2,091.94	2,202.42	2,102.19
Amount in ₹ Crore

Stanley Lifestyles Limited Financial Information (Restated Consolidated)

Stanley Lifestyles Limited's revenue increased by 42.94% and profit after tax (PAT) rose by 50.64% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	581.54	458.19	422.15	346.52
Revenue	322.29	425.62	297.76	201.71
Profit After Tax	18.70	34.98	23.22	1.92
Net Worth	237.21	216.50	199.76	182.93
Reserves and Surplus	225.83	207.88	191.31	174.96
Total Borrowing	30.90	9.37	6.09	0.25
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

98.90%

67.36%

Promoter Shareholding (Post-Issue)

78.24%

56.81%

P/E Ratio

34.55

54.43

Market Cap

₹19029.89 Cr.

₹2103.94 Cr.

ROE

16.90%%

7.92%%

ROCE

19.37%%

8.63%%

Debt/Equity

0.67

0.86

EPS

₹29.17

₹6.78

RoNW

16.87%%

8.34%%

Shares Offered

In the Emcure Pharma IPO retail investors (RII) are offered 67,43,160 shares while in Stanley Lifestyles IPO retail investors are offered 67,43,160 shares. Qualified institutional buyers (QIB) are offered 38,53,234 shares in Emcure Pharma IPO and 29,10,702 shares in Stanley Lifestyles IPO.

	Emcure Pharma IPO	Stanley Lifestyles IPO
Anchor Investor Reserveration	57,79,850 shares	43,66,051 shares
Market Maker Reserveration
QIB	38,53,234 shares	29,10,702 shares
NII	28,89,926 shares	21,83,026 shares
RII	67,43,160 shares	50,93,728 shares
Employee	1,08,900 shares	0 shares
Others
Total	1,37,03,538 shares	1,01,87,456 shares

Bids Received (Subscription)

Emcure Pharma IPO subscribed 67.87x in total, whereas Stanley Lifestyles IPO subscribed 97.16x.

	Emcure Pharma IPO	Stanley Lifestyles IPO
QIB (times)	191.24x	215.62x
NII (times)	49.32x	121.42x
Big NII (times)	54.90x	136.75x
Small NII (times)	38.16x	90.76x
RII (times)	7.36x	19.08x
Employee (times)	8.81x
Other (times)
Total (times)	67.87x	97.16x

Compare with others

Emcure Pharma IPO	Stanley Lifestyles IPO
Brainbees Solutions (Firstcry) IPO	Bansal Wire IPO
Ceigall India IPO	Emcure Pharma IPO
Akums Drugs and Pharmaceuticals IPO	OLA Electric IPO
Sanstar IPO	Vraj Iron and Steel IPO
Bansal Wire IPO	Aasaan Loans IPO
OLA Electric IPO	DEE Piping Systems IPO
Vraj Iron and Steel IPO	ixigo IPO
Aasaan Loans IPO	Kronox Lab Sciences IPO
Stanley Lifestyles IPO	Awfis Space Solutions IPO
DEE Piping Systems IPO	Go Digit IPO

Comments

Add a public comment...